Literature DB >> 9669722

Intestinal, pancreatic and hepatic involvement in carbohydrate-deficient glycoprotein syndrome type I.

B Kristiansson1, S Borulf, N Conradi, C Erlanson-Albertsson, W Ryd, H Stibler.   

Abstract

BACKGROUND: Children with carbohydrate-deficient glycoprotein syndrome type I during infancy have gastrointestinal symptoms and growth impairment, the cause of which is largely unknown.
METHODS: Seven children were investigated with small intestinal biopsy, liver biopsy, duodenal intubation with determination of lipolytic and proteolytic activity, and test meal. Weight, length-height, and head circumference were recorded regularly.
RESULTS: Growth was affected from early infancy, with an initial low rate of weight gain followed by impaired linear growth. Vomiting and diarrhea were dominant symptoms. Four of seven children had abnormal findings in light microscopic examination of small intestinal biopsy specimens, with short villi and increased inflammatory cells in the stroma, that did not respond to elimination of such food proteins as cow's milk or gluten. Electron microscopic study showed dilatation of smooth endoplasmic reticulum and abnormal inclusions containing lipids. The liver was abnormal in all. Besides steatosis and fibrosis or cirrhosis, there was a remarkable increase of inflammatory cells in portal zones. Activity of lipolytic enzymes in duodenal juice was low, except in one child, who no longer had growth problems or symptoms. Two of six had abnormal proteinolytic activity in duodenal juice. Digestion of triglycerides and absorption were within normal limits, as was the absorption of glucose and xylose.
CONCLUSIONS: Inflammation of small intestine and liver may be the cause of gastrointestinal symptoms. In all likelihood, the growth failure was because of low caloric intake and increased losses related to vomiting. Growth and gastrointestinal symptoms improved spontaneously as time elapsed.

Entities:  

Mesh:

Year:  1998        PMID: 9669722     DOI: 10.1097/00005176-199807000-00005

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  6 in total

1.  Reduced heparan sulfate accumulation in enterocytes contributes to protein-losing enteropathy in a congenital disorder of glycosylation.

Authors:  V Westphal; S Murch; S Kim; G Srikrishna; B Winchester; R Day; H H Freeze
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

2.  DMP1-CDG (CDG1e) with Significant Gastrointestinal Manifestations; Phenotype and Genotype Expansion.

Authors:  C Bursle; D Brown; J Cardinal; F Connor; S Calvert; D Coman
Journal:  JIMD Rep       Date:  2016-08-02

3.  DFT investigation on the reaction mechanism catalyzed by α-phosphomannomutase1 in protonated/deprotonated states.

Authors:  Hui-Ying Chu; Qing-Chuan Zheng; Xue Li; Yong-Shan Zhao; Ji-Long Zhang; Hong-Xing Zhang
Journal:  J Mol Model       Date:  2010-05-30       Impact factor: 1.810

4.  Prepubertal growth in congenital disorder of glycosylation type Ia (CDG-Ia).

Authors:  S Kjaergaard; J Müller; F Skovby
Journal:  Arch Dis Child       Date:  2002-10       Impact factor: 3.791

Review 5.  Histopathology of intestinal villi in neonatal and paediatric age: main features with clinical correlation - Part I.

Authors:  Chiara Rossi; Gloria Simoncelli; Giovanni Arpa; Alessandra Stracuzzi; Paola Parente; Matteo Fassan; Alessandro Vanoli; Vincenzo Villanacci
Journal:  Pathologica       Date:  2021-12-02

6.  Fibrotic response in fibroblasts from congenital disorders of glycosylation.

Authors:  M Rita Lecca; Charlotte Maag; Eric G Berger; Thierry Hennet
Journal:  J Cell Mol Med       Date:  2011-08       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.